Misplaced Pages

Kathy Giusti

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Kathy Giusti
Kathy Giusti in 2021
Born1958
EducationBachelor of Science in Nursing
Alma mater
Occupations
  • Co-founder, Multiple Myeloma Research Foundation (MMRF)
  • Co-chair, Harvard Business School (HBS) Kraft Precision Medicine Accelerator
SpousePaul Giusti
Children2

Kathy Giusti is a business leader, healthcare professional, and author. She is a two-time cancer survivor having been diagnosed with multiple myeloma and breast cancer. Kathy Co-Founded the Multiple Myeloma Research Foundation (the MMRF) where she was CEO and president for nearly two decades. She also co-chaired the Harvard Business School (HBS) Kraft Precision Medicine Accelerator, which she helped found, and was a Senior Fellow at Harvard Business School.

Giusti has been named one of Time magazine's 100 Most Influential People in the world. and named one of Fortune's list of Worlds' 50 Greatest Leaders.

Career

Early career

Giusti held executive positions in consumer marketing with Gillette/Procter & Gamble and in the pharmaceutical sector with Merck & Co. and G.D. Searle & Company (now Pfizer).

The Multiple Myeloma Research Foundation

In 1998, with her identical twin sister Karen Andrews, Giusti founded the Multiple Myeloma Research Foundation (the MMRF). The MMRF’s mission is to accelerate a cure for multiple myeloma patients.

As founder and CEO, Giusti has led the MMRF in establishing the Multiple Myeloma Research Consortium (MMRC), the MMRF CoMMpass™ study, CureCloud, the Right Track, and the Myeloma Investment Fund.

Under Giusti the MMRF has raised more than $500 million to fund research, 15 drugs have been approved to treat multiple myeloma, and many clinical trials are underway. These efforts have accelerated the pace at which treatments are brought to patients and more than tripled patients' survival.

Harvard Business School (HBS)

Giusti joined the Harvard Business School faculty as Senior Fellow, Co-Chairing the HBS Kraft Precision Medicine Accelerator, a $20 million endowed program provided by Robert Kraft and the Kraft Family Foundation. The Kraft Accelerator created The Kraft Precision Medicine Accelerator Playbook for Cures.

Diagnosis

In 1996, Kathy Giusti was diagnosed with multiple myeloma, an incurable blood cancer. When diagnosed, Giusti was 37 years old and was given three years to live. In 2022, Giusti was diagnosed with early-stage breast cancer as well.

Appointments

Giusti has been appointed to multiple positions and advisory boards, all with a focus on developing cures for cancer. These include:

  • National Cancer Advisory Board (NCAB)
  • National Institutes of Health All of US Research Program/Precision Medicine Initiative (PMI) Working Group
  • Faster Cures Advisory Board Changemakers
  • IMS Board
  • EQRx Board

Recognition

Giusti has received numerous awards for her leadership:  

  • Named one of Time magazine's 100 Most Influential People in the world
  • Ranked #19 on Fortune's list of Worlds' 50 Greatest Leaders
  • Recognized as 1 of 34 leaders changing healthcare by Fortune magazine
  • Named an Open Science Champion of Change by the White House
  • Presented the Harvard Business School Alumni Achievement Award
  • Received the Leadership in Personalized Medicine Award by the Personalized Medicine Coalition.
  • Presented the 2021 American Association for Cancer Research Distinguished Public Service Award
  • Named the Healthcare Businesswomen's Association's Woman of the Year Award

Publications

Kathy has authored or co-authored multiple articles in business, consumer, and scientific publications:

References

  1. ^ Mukherjee, Sy (2016-05-22). "These 3 Former Business Leaders Are Disrupting Medicine". Fortune. Retrieved 2021-02-19.
  2. Kerr, Nancy (20 February 2024). "'Fatal to Fearless': Facing a Deadly Cancer Diagnosis and Fighting Back". AARP. Retrieved 28 October 2024.
  3. ^ "About the Multiple Myeloma Research Foundation | The MMRF". themmrf.org. Retrieved 2021-02-19.
  4. ^ "Kraft Accelerator - Harvard Business School". www.hbs.edu. Retrieved 2021-02-19.
  5. ^ Young, Susan (24 October 2016). "Health Care Pioneer Giusti Named McCance Senior Fellow at HBS". www.alumni.hbs.edu. Retrieved 2021-02-19.
  6. Couric, Katie (2011-04-21). "The 2011 TIME 100 - TIME". Time. ISSN 0040-781X. Retrieved 2021-02-19.
  7. Goyette, Jay (2014-03-24). "UVM Alumna Kathy Giusti Named One of Fortune Magazine's 'World's 50 Greatest Leaders'". www.uvm.edu. Retrieved 2021-02-19.
  8. ^ "Giving hope and inspiration to cancer patients around the globe". www.alumni.hbs.edu. 24 April 2014. Retrieved 2021-02-19.
  9. MMRF (2020-07-14). "MMRF Launches CureCloud to Democratize Healthcare for Cancer Patients". themmrf.org. Archived from the original on August 6, 2020. Retrieved 2021-02-19.
  10. Giusti, Kathy; Marcus, Lori Tauber (12 February 2019). "4 Important Steps to Take After a Cancer Diagnosis". Time. Retrieved 2021-02-19.
  11. MMRF (2019-04-23). "Multiple Myeloma Research Foundation (MMRF) Launches Innovative Fund to Accelerate New Myeloma Treatments". themmrf.org. Archived from the original on October 24, 2020. Retrieved 2021-02-19.
  12. MMRF (2020-12-04). "The MMRF Drives Unparalleled Advances for Multiple Myeloma Patients". themmrf.org. Archived from the original on January 26, 2021. Retrieved 2021-02-19.
  13. "Use the Tools". www.hbs.edu. Retrieved 2021-02-19.
  14. Kincaid, Ellie (2018-03-26). "She Was Given Three Years To Live. So She Transformed Cancer Research". Forbes. Retrieved 2021-02-19.
  15. Giusti, Kathy (17 June 2022). "I've Been Diagnosed With Two Different Cancers—This Is What I've Learned". Prevention. Retrieved 2022-06-17.Giusti
  16. "Kathy Giusti, M.B.A." National Institutes of Health (NIH). 2020-08-27. Retrieved 2021-02-19.
  17. "FasterCures Changemakers: Disruptive Philanthropy for Patients". milkeninstitute.org. Archived from the original on August 14, 2020. Retrieved 2021-02-19.
  18. "Multiple Myeloma Research Foundation (MMRF) Founder, CEO Receives American Society of Clinical Oncology's Partners In Progress Award". BioSpace. Retrieved 2021-02-19.
  19. "EQRx Appoints Kathy Giusti to Board of Directors". EQRx. 2021-09-27. Archived from the original on September 27, 2021. Retrieved 2021-09-27.
  20. "34 Leaders Who Are Changing Health Care". Fortune. Retrieved 2021-02-19.
  21. Giusti, Kathy (2013-06-20). "Democratizing the Science, Accelerating the Cure". whitehouse.gov. Retrieved 2021-02-19.
  22. "Kathryn E. Giusti, MBA 1985". www.alumni.hbs.edu. January 2009. Retrieved 2021-02-19.
  23. "Personalized Medicine Coalition - Advocates for precision medicine : PMC Press Releases : Press Releases : Personalized Medicine Coalition Recognizes Kathy Giusti with Award for Leadership". www.personalizedmedicinecoalition.org. Archived from the original on March 18, 2015. Retrieved 2021-02-19.
  24. "Giusti, Pelosi, and Sawyers to Receive American Association for Cancer Research Distinguished Public Service Awards | News Releases". American Association for Cancer Research (AACR). 2021-04-05. Retrieved 2021-04-21.
  25. "Woman of the Year Past Recipients | HBA". www.hbanet.org. Archived from the original on May 22, 2015. Retrieved 2021-02-19.
  26. "Reducing Racial Disparities in Cancer Treatment Demands Collective Action". Harvard Business Review. 2022-06-13. Retrieved 2022-06-13.
  27. "Reducing Racial Disparities in Cancer Outcomes". Harvard Business Review. 2022-01-17. Retrieved 2022-01-17.
  28. "Addressing Demographic Disparities in Clinical Trials". Harvard Business Review. 2021-06-11. ISSN 0017-8012. Retrieved 2021-06-21.
  29. "A New Playbook for Cure-Seeking Nonprofits". The Journal of Precision Medicine. Retrieved 2021-02-19.
  30. "How Nonprofit Foundations Can Sustainably Fund Disease Research". Harvard Business Review. 2020-09-30. ISSN 0017-8012. Retrieved 2021-02-19.
  31. "What It Takes to Lead a Disease Research Foundation". Harvard Business Review. 2020-08-18. ISSN 0017-8012. Retrieved 2021-02-19.
  32. "How Medical Nonprofits Set Winning Strategy". Harvard Business Review. 2020-03-06. ISSN 0017-8012. Retrieved 2021-02-19.
  33. "One Obstacle to Curing Cancer: Patient Data Isn't Shared". Harvard Business Review. 2016-11-28. ISSN 0017-8012. Retrieved 2021-02-19.
  34. "What Cancer Researchers Can Learn from Direct-to-Consumer Companies". Harvard Business Review. 2017-01-12. ISSN 0017-8012. Retrieved 2021-02-19.
  35. Giusti, Kathy; Young, Anne Quinn; Lehrhaupt, Kerri (May–June 2018). "Closing Knowledge Gaps to Optimize Patient Outcomes and Advance Precision Medicine". Cancer Journal (Sudbury, Mass.). 24 (3): 144–151. doi:10.1097/PPO.0000000000000319. ISSN 1540-336X. PMID 29794540. S2CID 44094784.
  36. Giusti, Kathy; Young, Anne Quinn; Winget, Melissa; Lehrhaupt, and Kerri (2017-04-11). "Understanding Differences in Critical Decisions in the Multiple Myeloma Patient Journey in the Era of Precision Medicine". American Journal of Hematology/Oncology. 13 (3).

External links

Categories: